These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 29721615)

  • 1. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients.
    Zhou W; Herwald SE; Uppot RN; Arellano RS
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
    Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G
    Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
    Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
    Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma.
    Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
    Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
    J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer.
    Lorber G; Glamore M; Doshi M; Jorda M; Morillo-Burgos G; Leveillee RJ
    Urol Oncol; 2014 Oct; 32(7):1017-23. PubMed ID: 24996776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy.
    Gebauer B; Werk M; Lopez-Hänninen E; Felix R; Althaus P
    Cardiovasc Intervent Radiol; 2007; 30(4):644-9. PubMed ID: 17436034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma.
    Welch BT; Callstrom MR; Morris JM; Kurup AN; Schmit GD; Weisbrod AJ; Lohse CM; Kohli M; Costello BA; Olivier KR; Thompson RH; Boorjian SA; Atwell TD
    J Urol; 2014 Aug; 192(2):357-63. PubMed ID: 24631107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
    Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
    J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Assessment of Chronic Kidney Disease following Microwave Ablation for Stage T1 Renal Cell Carcinoma.
    Zhou W; Herwald SE; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2018 Dec; 29(12):1685-1691. PubMed ID: 30297311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous Ablation Versus Nephrectomy for Small Renal Masses: Clinical Outcomes in a Single-Center Cohort.
    Lourenco P; Bilbey N; Gong B; Bahrabadi A; Halkier B
    Cardiovasc Intervent Radiol; 2018 Dec; 41(12):1892-1900. PubMed ID: 30088062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma.
    Takaki H; Soga N; Kanda H; Nakatsuka A; Uraki J; Fujimori M; Yamanaka T; Hasegawa T; Arima K; Sugimura Y; Sakuma H; Yamakado K
    Radiology; 2014 Jan; 270(1):292-9. PubMed ID: 23925272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging.
    Atwell TD; Kurup AN; Boorjian SA; Schmitz JJ; Thompson RH; Leibovich BC; Schmit GD
    J Vasc Interv Radiol; 2017 Dec; 28(12):1651-1657. PubMed ID: 29042169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
    Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage surgery after energy ablation for renal masses.
    Karam JA; Wood CG; Compton ZR; Rao P; Vikram R; Ahrar K; Matin SF
    BJU Int; 2015 Jan; 115(1):74-80. PubMed ID: 24656119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local Recurrence of Renal Cancer After Surgery: Prime Time for Percutaneous Thermal Ablation?
    Monfardini L; Varano GM; Foà R; Della Vigna P; Bonomo G; Orsi F
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1542-7. PubMed ID: 25902857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.